all about terminal illnesses
← All diseases Liver, kidneys and digestion

Primary biliary cholangitis

Do you want to receive a message when there is new research about Primary Biliary Cholangitis? This is possible with an account. Create a free account or log in.

Last updated: 2026-08-09 · automatically checked, spot-checked

# Primary Biliary Cholangitis

What is it

Primary Biliary Cholangitis (PBC) is a rare, slowly progressive disease in which the immune system attacks the small bile ducts in the liver. These bile ducts (intrahepatic bile ducts) carry bile, a substance that helps digest fats. The ongoing inflammation gradually damages and destroys these ducts.

It is an autoimmune disease: the body turns against its own tissue. PBC is not contagious and does not result from lifestyle habits. The disease occurs worldwide but is relatively rare. It affects more women than men, typically from middle age onwards, although younger people can also develop it.

Causes

The exact cause of PBC is not fully understood. Research points to a combination of factors:

- **Genetic predisposition**: certain inherited characteristics make some people more susceptible
- **Environmental factors**: exposure to certain substances in the environment may play a role
- **Immune system failure**: the body produces antibodies (especially anti-mitochondrial antibodies, or AMA for short) that target parts of body cells, in this case in the bile ducts
- **Bacterial influences**: certain bacteria in the gut may trigger the immune system

Most patients have detectable autoantibodies in their blood, which helps in recognizing the disease.

How the disease progresses

PBC usually progresses in stages, although not everyone goes through all phases and the speed varies greatly between individuals.

**Early stage**: The inflammation concentrates around the bile duct. Many people have few or no symptoms at this stage and are often discovered by chance through abnormalities in blood tests.

**Intermediate phase**: The inflammation spreads; more bile duct cells are damaged. Symptoms may now become visible. Bile backs up in the liver (cholestasis).

**Advanced stage**: Ongoing damage leads to scar tissue (fibrosis) in the liver. The liver structure changes, and its function decreases. This can eventually lead to liver cirrhosis, where almost all liver tissue is replaced by scars.

**Terminal phase**: In severe cirrhosis, the liver can no longer function adequately. This can lead to liver failure and, without intervention, to liver transplantation.

Important: this progression can take ten to twenty years, but can also be slower. Some people experience long periods of stabilization.

Symptoms by phase

**Early stage:**
- Often no symptoms; discovery happens at routine check-up
- Sometimes mild fatigue or non-specific tiredness

**Intermediate phase (when symptoms occur):**
- Itching (pruritis), sometimes severe, especially in the evening or after showering
- Fatigue and lack of energy
- Pain or discomfort in the abdomen, especially upper right
- Yellowing of skin and eyes (jaundice), due to bile accumulation
- Dark urine and pale stools
- Upper right abdomen swollen (enlarged liver)
- Abdominal fluid (ascites), causing the abdomen to swell

**Advanced stage:**
- All previous symptoms may worsen
- Weight loss
- Bleeding tendencies (for example nosebleeds or gum bleeding)
- Confusion (hepatic encephalopathy)
- Food intolerances, especially for fats
- Bone fractures (osteoporosis due to vitamin deficiency)

Note: symptoms are highly individual; two people with the same severity may have very different complaints.

What it means for daily life

The impact depends on the stage and severity of symptoms.

**Itching** can be very burdensome and greatly interfere with sleep, work, and social activities. For many, this is one of the most difficult aspects. There are ways to manage it, but itching does not always respond well to treatment.

**Fatigue** can be so profound that small activities feel exhausting. This is also known as 'fatigue' and differs from normal tiredness.

**Nutrition**: many patients need to eat low-fat or specially prepared food due to digestion problems. The body absorbs certain vitamins poorly, making supplementation necessary.

**Work**: in early stages, many people can work full-time. As the disease progresses, part-time or work-from-home arrangements may be needed. Some must stop working.

**Social contact**: itching, fatigue and limited energy can make social contact difficult.

**Relationships**: chronic illness requires adjustments and can impact partnerships and sexual wellbeing.

**Multiple hospital visits**: regular tests, check-ups and possibly treatments are necessary.

PBC therefore makes many demands, but many patients learn to manage it and remain stable for years.

Outlook

The outlook for PBC has improved considerably over the past twenty years through better diagnosis and treatment.

**Survival rates** at population level show that patients diagnosed in the early stage survive on average much longer than in previous decades. Some patients achieve normal life expectancy. This depends heavily on when the disease is detected and how well one responds to treatment.

**Treatment**: there are medicines that can slow or even stop progression. The aim is to delay or prevent liver damage for as long as possible. Not everyone responds equally well to the same medicine, so adjustments are sometimes needed.

**Research**: researchers continually work to better understand PBC and develop new treatment options. This offers perspective on improvements in the coming years.

**Liver transplantation**: for patients with terminal liver cirrhosis, liver transplantation is possible. This can be life-saving, although this major procedure requires extensive preparation and carries risks. After transplantation, patients can live stable lives for years, although they must take medication for life.

**Prognostic factors**: certain markers in blood and tissue biopsies help doctors estimate how severely the disease progresses. This helps in choosing treatment.

It is important to know that outlooks at group level are statements; for one person, much depends on individual factors that only the treating physician can assess.

Frequently asked questions

**Can PBC be cured?**
At present, PBC cannot be cured, but it can be treated and slowed down. There are medicines that can prevent the disease from getting worse, and for some the damage can even stabilize. Intensive research is aimed at new possibilities.

**Is PBC hereditary? Can I pass it on to my children?**
PBC itself is not hereditary in the strict sense, but genetic susceptibility can run in families. This does not mean children will definitely get it; many factors play a role. Doctors sometimes advise relatives to be alert to symptoms, but there is no way to actively pass on PBC.

**What is the difference with primary sclerosing cholangitis (PSC)?**
Both are autoimmune diseases that affect bile ducts, but PSC mainly affects the larger bile ducts outside the liver and occurs more often with inflammatory bowel disease. PBC affects the small bile ducts in the liver. Recognition and treatment differ.

**Can I continue to work and live normally?**
This depends on your individual disease course. Many people in the early stage can work full-time and lead a normal life. As the disease progresses, adjustment may be needed. This is something you discuss together with your doctor and employer.

---

_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._

In figures

No global mortality figures

This disease is too rare to have its own place in global mortality statistics. The WHO counts it in a collection group, and no separate figure can be extracted from that.

No survival figures

Survival is systematically tracked in cancer registries. Such a registry does not exist for this disease, so there are no comparable figures on how many people are still alive five years after diagnosis.

A figure about thousands of people says nothing about one person. These figures concern all ages, health conditions and healthcare systems combined. What they mean for your situation can only be determined by your own healthcare provider.

↑ Back to top

Sources used

Above each source is stated in one sentence what the research is about, so you do not have to rely on an English technical title. More studies on Primary biliary cholangitis can be found at publications and studies.

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.